Cargando…

Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report

BACKGROUND: Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms of uncertain malignant potential, which have in common the co-expression of muscle and melanocytic immunohistochemical markers. CASE PRESENTATION: A 48-year-old man presented with dysuria, passage of urinary se...

Descripción completa

Detalles Bibliográficos
Autores principales: Parfitt, Jeremy R, Bella, Anthony J, Wehrli, Bret M, Izawa, Jonathan I
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564030/
https://www.ncbi.nlm.nih.gov/pubmed/16925812
http://dx.doi.org/10.1186/1471-2490-6-20
_version_ 1782129537321009152
author Parfitt, Jeremy R
Bella, Anthony J
Wehrli, Bret M
Izawa, Jonathan I
author_facet Parfitt, Jeremy R
Bella, Anthony J
Wehrli, Bret M
Izawa, Jonathan I
author_sort Parfitt, Jeremy R
collection PubMed
description BACKGROUND: Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms of uncertain malignant potential, which have in common the co-expression of muscle and melanocytic immunohistochemical markers. CASE PRESENTATION: A 48-year-old man presented with dysuria, passage of urinary sediment and lower abdominal discomfort. A three centimeter mass was identified by cystoscopy in the posterior midline of the bladder. Computerized tomography suggested an enterovesical fistula. The patient underwent laparotomy, partial cystectomy and partial small bowel resection. Pathological examination revealed PEComa of the bladder. The patient underwent adjuvant interferon-α immunotherapy. Subsequent follow-up procedures, including cystoscopy and imaging, have not revealed evidence of recurrence. The patient is clinically free of disease 48 months after surgery. CONCLUSION: This case represents the second documented PEComa of bladder and demonstrates that adjuvant therapies, including anti-angiogenic and immunotherapy, may be considered for patients with locally advanced or metastatic genitourinary PEComa.
format Text
id pubmed-1564030
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15640302006-09-12 Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report Parfitt, Jeremy R Bella, Anthony J Wehrli, Bret M Izawa, Jonathan I BMC Urol Case Report BACKGROUND: Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms of uncertain malignant potential, which have in common the co-expression of muscle and melanocytic immunohistochemical markers. CASE PRESENTATION: A 48-year-old man presented with dysuria, passage of urinary sediment and lower abdominal discomfort. A three centimeter mass was identified by cystoscopy in the posterior midline of the bladder. Computerized tomography suggested an enterovesical fistula. The patient underwent laparotomy, partial cystectomy and partial small bowel resection. Pathological examination revealed PEComa of the bladder. The patient underwent adjuvant interferon-α immunotherapy. Subsequent follow-up procedures, including cystoscopy and imaging, have not revealed evidence of recurrence. The patient is clinically free of disease 48 months after surgery. CONCLUSION: This case represents the second documented PEComa of bladder and demonstrates that adjuvant therapies, including anti-angiogenic and immunotherapy, may be considered for patients with locally advanced or metastatic genitourinary PEComa. BioMed Central 2006-08-22 /pmc/articles/PMC1564030/ /pubmed/16925812 http://dx.doi.org/10.1186/1471-2490-6-20 Text en Copyright © 2006 Parfitt et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Parfitt, Jeremy R
Bella, Anthony J
Wehrli, Bret M
Izawa, Jonathan I
Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report
title Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report
title_full Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report
title_fullStr Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report
title_full_unstemmed Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report
title_short Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report
title_sort primary pecoma of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564030/
https://www.ncbi.nlm.nih.gov/pubmed/16925812
http://dx.doi.org/10.1186/1471-2490-6-20
work_keys_str_mv AT parfittjeremyr primarypecomaofthebladdertreatedwithprimaryexcisionandadjuvantinterferonalphaimmunotherapyacasereport
AT bellaanthonyj primarypecomaofthebladdertreatedwithprimaryexcisionandadjuvantinterferonalphaimmunotherapyacasereport
AT wehrlibretm primarypecomaofthebladdertreatedwithprimaryexcisionandadjuvantinterferonalphaimmunotherapyacasereport
AT izawajonathani primarypecomaofthebladdertreatedwithprimaryexcisionandadjuvantinterferonalphaimmunotherapyacasereport